Timothy D. Gilligan, MD
Disclosures: Nothing to disclose - 06/10/2021

Timothy Gilligan, MD, MS, FASCO, FACH

Brief Bio 2022


Dr. Timothy Gilligan is a medical oncologist, Vice-Chair for Education, and Associate Professor of Medicine at the Cleveland Clinic Taussig Cancer Institute. He also serves as the Diversity, Equity and Inclusion Officer for the Graduate Medical Education Council at Cleveland Clinic. Previously, he served for nearly a decade as the hematology/oncology fellowship program director at Cleveland Clinic. He has been elected to serve as the President of the Academy of Communication in Healthcare for the calendar years 2023 and 2024.


Dr. Gilligan is a widely recognized expert in testicular germ cell tumors. He currently chairs the NCCN Testis Cancer guideline panel and is one of the two testis cancer section editors for UpToDate. He has served on guideline panels for the National Cancer Institute and the American Urological Association and has published numerous review articles and book chapters on the subject, and has spoken on testis cancer at major oncology conferences, including ASCO, ASTRO, and the Society of Urologic Oncology. At Cleveland Clinic and other hospitals and at national and international conferences, he also teaches communication skills, conflict engagement, team-building, and coaching, and trains others to teach communication skills. In addition, he co-chaired the ASCO panels that wrote the society’s guidelines on patient-clinician communication (2017) and on the use of serum tumor markers for adult males with germ cell tumors (2010).


Dr. Gilligan graduated from Swarthmore College, Stanford University School of Medicine and Columbia University Graduate School of Journalism. He trained in internal medicine and medical oncology at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. He completed the Academy on Communication in Healthcare three-year faculty training program and is an ACH Fellow and member of their faculty.